Header Logo

STEPHANIE FETZKO

Concepts (43)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rhabdomyosarcoma
2
2024
208
1.330
 Why?
Salvage Therapy
1
2024
173
0.810
 Why?
Neoplasm Recurrence, Local
3
2024
1205
0.720
 Why?
Hematologic Neoplasms
2
2023
285
0.680
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1282
0.540
 Why?
Neoplasms
1
2023
2778
0.300
 Why?
Rhabdomyosarcoma, Embryonal
1
2022
52
0.180
 Why?
Killer Cells, Natural
1
2023
330
0.170
 Why?
Soft Tissue Neoplasms
1
2022
126
0.170
 Why?
White Matter
1
2022
206
0.160
 Why?
Brain Diseases
1
2022
282
0.160
 Why?
Diagnostic Imaging
1
2022
272
0.160
 Why?
Survival Rate
1
2024
2025
0.160
 Why?
Sarcoma
1
2022
204
0.160
 Why?
Proportional Hazards Models
1
2022
1338
0.140
 Why?
Immunotherapy, Adoptive
1
2023
843
0.130
 Why?
3-Iodobenzylguanidine
1
2016
12
0.130
 Why?
Retrospective Studies
3
2024
16569
0.130
 Why?
Infant
4
2024
12733
0.120
 Why?
Radiopharmaceuticals
1
2016
159
0.120
 Why?
Follow-Up Studies
1
2024
5042
0.120
 Why?
Prognosis
1
2024
4629
0.120
 Why?
Neoplasms, Second Primary
1
2016
140
0.110
 Why?
Young Adult
3
2024
9535
0.110
 Why?
Child, Preschool
3
2024
14341
0.100
 Why?
Neuroblastoma
1
2016
534
0.090
 Why?
Adolescent
3
2024
19921
0.080
 Why?
Risk Factors
1
2024
10275
0.080
 Why?
Humans
6
2024
124973
0.080
 Why?
Antineoplastic Agents
1
2016
1725
0.060
 Why?
Child
2
2024
25038
0.060
 Why?
Adult
2
2024
30051
0.060
 Why?
Male
3
2024
61670
0.050
 Why?
Female
3
2024
67493
0.050
 Why?
Proto-Oncogene Proteins
1
2022
580
0.040
 Why?
Repressor Proteins
1
2022
759
0.030
 Why?
Seizures
1
2022
854
0.030
 Why?
Myelodysplastic Syndromes
1
2016
122
0.030
 Why?
Age of Onset
1
2016
605
0.030
 Why?
Biomarkers, Tumor
1
2022
1538
0.030
 Why?
Combined Modality Therapy
1
2016
1222
0.020
 Why?
Magnetic Resonance Imaging
1
2022
3555
0.020
 Why?
Risk Assessment
1
2016
3389
0.020
 Why?
FETZKO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (43)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_